Clinical InvestigationHigh rates of death and hospitalization follow bone fracture among hemodialysis patients
Keywords
Cited by (0)
The DOPPS is administered by Arbor Research Collaborative for Health and is supported by scientific research grants from Amgen (since 1996), Kyowa Hakko Kirin (since 1999, in Japan), Sanofi Renal (since 2009), AbbVie (since 2009), Baxter (since 2011), and Vifor Fresenius Renal Pharma (since 2011), without restrictions on publications. FT is supported in part by award number K01DK087762 from the National Institute of Diabetes and Digestive and Kidney Diseases. FT has received honoraria from Amgen, Dialysis Clinic, and Renal Research Institute. BMR has received speaker fees for Kyowa Hakko Kirin. RLP has received speaker fees from Amgen, Kyowa Hakko Kirin, and Vifor, has served as a consultant for Pursuit Vascular, and has served on an advisory panel for Merck. BDB and RDK work in the Center for Observational Research at Amgen. All the other authors declared no competing interests.